ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 53 filers reported holding ADC THERAPEUTICS SA in Q1 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,972,293 | -41.2% | 513,618 | -26.2% | 0.04% | -43.8% |
| Q3 2022 | $3,356,000 | -52.5% | 696,263 | -21.7% | 0.06% | -67.2% |
| Q2 2022 | $7,065,000 | +93.7% | 888,700 | +257.8% | 0.20% | +99.0% |
| Q1 2022 | $3,648,000 | +297.0% | 248,354 | +446.1% | 0.10% | +237.9% |
| Q4 2021 | $919,000 | – | 45,478 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 1,186,215 | $4,555,066 | 2.69% |
| Blue Owl Capital Holdings LP | 733,568 | $2,816,901 | 1.20% |
| Redmile Group, LLC | 7,590,849 | $29,148,860 | 1.19% |
| AlphaCentric Advisors LLC | 297,500 | $1,142,400 | 1.13% |
| Prosight Management, LP | 463,310 | $1,779,110 | 0.97% |
| GCM Grosvenor Holdings, LLC | 735,471 | $2,824,209 | 0.72% |
| Indie Asset Partners, LLC | 93,839 | $360,342 | 0.40% |
| XTX Topco Ltd | 197,635 | $758,918 | 0.16% |
| Eventide Asset Management | 1,879,959 | $7,219,043 | 0.14% |
| Nantahala Capital Management | 243,290 | $934,234 | 0.06% |